Adrian Veres

Adrian is the Chief Scientific Officer and a co-founder of Dyno Therapeutics. He leads Dyno’s research on engineering highly improved AAV gene delivery and works closely with Dyno partners to develop CNS, Muscle and Ophtha gene therapies leveraging Dyno’s improved AAV. He holds an MD with Honors from the Harvard-MIT Health Sciences and Technology program and earned a PhD in Systems Biology from Harvard University, previously working in the area of stem-cell derived therapeutics for Type 1 Diabetes.